These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 3807823)
21. A study of cefotaxime versus netilmicin versus netilmicin and cefotaxime in serious infections. Sen RA; Keaney MG; Ganguli LA J Chemother; 1989 Jul; 1(4 Suppl):652-4. PubMed ID: 16312576 [No Abstract] [Full Text] [Related]
22. [The use of cefotaxime against infections (author's transl)]. Lepeu G; Bertrand A; Armengaud M; Aubertin J Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600 [TBL] [Abstract][Full Text] [Related]
23. [Suppurative surgical infection in newborn infants and the clinico-immunological effect of using dekaris]. Samsygin SA; Dolgina EN; Romanova LA; Shevochkina GI; Ovchinnikova EA Khirurgiia (Mosk); 1986 Aug; (8):21-6. PubMed ID: 3761926 [No Abstract] [Full Text] [Related]
24. [Cefotaxime in infections caused by multi-resistant microorganisms]. Aguirre M; Torres A; Alés JM Rev Clin Esp; 1981 Jan; 160(1):15-8. PubMed ID: 6259703 [No Abstract] [Full Text] [Related]
25. Effect of formulary restriction of cefotaxime usage. DeVito JM; John JF Arch Intern Med; 1985 Jun; 145(6):1053-6. PubMed ID: 4004430 [TBL] [Abstract][Full Text] [Related]
26. Cefotaxime in the treatment of lower respiratory tract infections. Beumer HM; Veldkamp J; Deleers L Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367 [TBL] [Abstract][Full Text] [Related]
27. Experience with the third generation cephalosporins, cefoperazone and cefotaxime: report. Reddy J N Z Med J; 1984 May; 97(755):293-6. PubMed ID: 6328390 [TBL] [Abstract][Full Text] [Related]
28. [Conservative treatment of diabetic gangrene by means of continuous intra-arterial perfusion]. Calvet JM Diabete; 1968 Sep; ():Suppl:62-7. PubMed ID: 5759340 [No Abstract] [Full Text] [Related]
29. [Methods of catheterization of the inferior epigastric artery and long-term intra-arterial infusion of drugs in the treatment of chronic osteomyelitis of the lower extremities]. Kanorskiĭ ID; Svetukhin AM Sov Med; 1973 Oct; 36(10):94-9. PubMed ID: 4789222 [No Abstract] [Full Text] [Related]
30. [Clinical considerations on the use of cefotaxime in infectious complications after resuscitation]. Mangione S; Giannalia ML Minerva Anestesiol; 1983 Nov; 49(11):649-52. PubMed ID: 6322053 [No Abstract] [Full Text] [Related]
31. [Evaluation of the clinical activity of cefotiam (SCE 963). Multicentric study in 7 centers]. Bryskier A; Humbert G; Borsa F; Bertrand A; Janbon F; Lafaix C; Beucler A; Veyssier P; Dusehu E; Modai J Pathol Biol (Paris); 1983 May; 31(5):328-35. PubMed ID: 6312392 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of ceftizoxime and related compounds in animals models of infection. Actor P; Grappel SF J Antimicrob Chemother; 1982 Nov; 10 Suppl C():81-9. PubMed ID: 6296033 [No Abstract] [Full Text] [Related]
33. Clinical efficacy of cefotaxime in two different periods. Peralta S; Vitale B; Scarsi C; D'Aiello G; Rotondo G; Delle Vedove G; Rini GB J Chemother; 1989 Jul; 1(4 Suppl):648-9. PubMed ID: 16312574 [No Abstract] [Full Text] [Related]
34. [Use of cefotiam in the treatment of bacterial infections]. Mussini C; Zanni G; Braglia MP Clin Ter; 1984 Dec; 111(5):401-9. PubMed ID: 6097395 [No Abstract] [Full Text] [Related]
35. [Effect of flash chemoprophylaxis by cefotaxime on the appearance of postoperative bacterial superinfections in surgery of the prostate]. Joly-Guillou ML; Prokocimer P; Desmonts JM; Lemoine JF; Manuel C; Bergogne-Berezin E Pathol Biol (Paris); 1985 May; 33(5):325-9. PubMed ID: 3897961 [TBL] [Abstract][Full Text] [Related]
36. [Clinical experience in the treatment of gynecologic and obstetrical infections with cefotaxime]. Grcić R; Zivanović Z; Ivanović L; Stavrić V; Vucić V; Miscević L; Popović V; Prorocić M Med Pregl; 1985; 38(11-12):575-9. PubMed ID: 3835447 [No Abstract] [Full Text] [Related]